Caraway Therapeutics - Ownership and Business Overview

Life ScienceCompany

Caraway Therapeutics Ownership

Who owns Caraway Therapeutics?

Caraway Therapeutics is owned by Merck. It was acquired on November 21, 2023.

Caraway Therapeutics Business Overview

Where is Caraway Therapeutics headquartered?

Caraway Therapeutics is headquartered in Cambridge, Massachusetts.

What sector is Caraway Therapeutics in?

Caraway Therapeutics is a life science company.

When was Caraway Therapeutics founded?

Caraway Therapeutics was founded in 2017.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 196 acquisitions of life science companies in 2023, including 22 acquisitions by private equity firms, and 174 by strategics.

Caraway Therapeutics

Caraway Therapeutics, Inc.

300 Technology Square, Fl. 2,
Cambridge, Massachusetts 02139
United States,
(617) 245-8188
www.carawaytx.com

Caraway Therapeutics is specialized in treatment of neurodegenerative and rare diseases by targeting pathways informed by human genetics, and has built a pipeline of novel, small-molecule therapeutics for the treatment of these diseases. Caraway Therapeutics was founded in 2017 and is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.